IP Library Granted Patent US 10,036,757
Granted Patent B2
US 10,036,757 · App. 13/633,075 · Granted Jul 31, 2018

Addressable antibody arrays and methods of use

Inventors: Sharat Singh (Rancho Santa Fe, CA); Shui Long Wang (San Diego, CA)
Assignee: Nestec S.A.
G01N33/6854G01N33/564G01N33/6851G01N2800/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,036,757
App. No.
13/633,075
Granted
Jul 31, 2018
Kind
B2
Abstract

Systems and assay methods are disclosed for detecting an autoantibody in a sample. In certain instances, the systems and methods employ a mass tag releasably connected to an antigen. The tag is thereafter released for detection. A tag can be detected by mass spectrometry or in certain instances the tag is fluorescent. Methods for diagnosing a disease or disorder in a subject are also disclosed.

Claims (22)

1. A kit, the kit comprising:

a plurality of tagged antigens specific for an autoantibody, wherein the autoantibody is associated with a particular disease or disorder, wherein the plurality of tagged antigens transforms the autoantibody into an immunological pair, wherein said tagged antigen further comprises a first support binding member having affinity for an addressable support comprising a second binding member; and

a solid support having a binding member, wherein the binding member is specific for the immunological pair.

2. The kit of claim 1 , wherein said binding member is a protein which binds to said immunological pair.

3. The kit of claim 1 , wherein the binding member is selected from the group consisting of an antigen, an antibody, biotin, avidin, streptavidin, anti-biotin; folate, folate-binding protein, IgG, Protein A, Protein G, a carbohydrate, lectin, and a nucleic acid.

4. The kit of claim 1 , wherein the solid support is selected from the group consisting of polystyrene, cellulose, nitrocellulose, a glass bead, and a magnetic bead.

5. The kit of claim 4 , wherein the solid support is a magnetic bead.

6. The kit of claim 1 , wherein said autoantibody is derived from a subject having an autoimmune disease selected from the group consisting of rheumatoid arthritis, osteoarthritis, juvenile chronic arthritis, systematic lupus erythematosus, Sjogren's syndrome, ankylosing spondylitis, psoriatic arthritis, multiple sclerosis, inflammatory bowel disease, graft-vs-host disease, and scleroderma.

7. The kit of claim 1 , wherein said tagged antigen is a plurality of antigens on a support.

8. The kit of claim 1 , wherein said support is a hydrophilic molecule.

9. The kit of claim 8 , wherein said hydrophilic molecule is a polymer.

10. The kit of claim 9 , wherein said polymer is a member selected from the group consisting of polyethylene glycol, dextran, dextran carboxylic acid polyvinyl pyrrolidone, sugar alcohols, polyoxyethylene polyoxypropylene glycol, and a mixture thereof.

11. The kit of claim 1 , wherein said plurality of antigens is attached to said polymer in a “quick-attach” system.

12. The kit of claim 1 , wherein said autoantibody is a plurality of autoantibodies.

13. The kit of claim 12 , wherein said plurality of antigens is specific for said plurality of autoantibodies which form a plurality of immunological pairs.

14. The kit of claim 13 , wherein the increase in affinity from the formation of said plurality of immunological pairs allows for increased detection of a single immunological pair.

15. The kit of claim 1 , wherein said first binding member forms a bound pair with said second binding member on said addressable support.

16. The kit of claim 1 , wherein the kit is used to perform an assay method for detecting an autoantibody in a sample from a subject, wherein the method comprises:

(a) contacting the tagged antigen with a sample having an autoantibody specific for said tagged antigen to transform said autoantibody into an immunological pair;

(b) contacting said immunological pair with the solid support having a binding member specific for said immunological pair to transform said immunological pair into a protein complex;

(c) separating said protein complex from said sample to form an isolated protein complex; and

(d) releasing said tag from said isolated protein complex for detection.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2021
From: PROMETHEUS BIOSCIENCES, INC.
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 057452/0129 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CHANGE OF NAME Recorded Oct 17, 2019
From: PRECISION IBD, INC.
To: PROMETHEUS BIOSCIENCES, INC.
Reel/Frame 050886/0942 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2019
From: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
To: PRECISION IBD, INC.
Reel/Frame 050166/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2013
From: PROMETHEUS LABORATORIES INC.
To: NESTEC S.A.
Reel/Frame 029768/0149 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2013
From: SINGH, SHARAT; WANG, SHUI LONG
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 029766/0962 →
Continuity (5)
Continuation 12500553 · Jul 9, 2009
Continuation PCTUS2009037566 · Mar 18, 2009
Continuation In Part 12209863 · Sep 12, 2008
Provisional Application 60972724 · Sep 14, 2007
Related Publication 20130267431A1 · Oct 10, 2013
Cited By (1)
US 12,618,858